157 related articles for article (PubMed ID: 12460461)
1. Fuzzy neural network applied to gene expression profiling for predicting the prognosis of diffuse large B-cell lymphoma.
Ando T; Suguro M; Hanai T; Kobayashi T; Honda H; Seto M
Jpn J Cancer Res; 2002 Nov; 93(11):1207-12. PubMed ID: 12460461
[TBL] [Abstract][Full Text] [Related]
2. Multiple fuzzy neural network system for outcome prediction and classification of 220 lymphoma patients on the basis of molecular profiling.
Ando T; Suguro M; Kobayashi T; Seto M; Honda H
Cancer Sci; 2003 Oct; 94(10):906-13. PubMed ID: 14556665
[TBL] [Abstract][Full Text] [Related]
3. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.
Rosenwald A; Wright G; Chan WC; Connors JM; Campo E; Fisher RI; Gascoyne RD; Muller-Hermelink HK; Smeland EB; Giltnane JM; Hurt EM; Zhao H; Averett L; Yang L; Wilson WH; Jaffe ES; Simon R; Klausner RD; Powell J; Duffey PL; Longo DL; Greiner TC; Weisenburger DD; Sanger WG; Dave BJ; Lynch JC; Vose J; Armitage JO; Montserrat E; López-Guillermo A; Grogan TM; Miller TP; LeBlanc M; Ott G; Kvaloy S; Delabie J; Holte H; Krajci P; Stokke T; Staudt LM;
N Engl J Med; 2002 Jun; 346(25):1937-47. PubMed ID: 12075054
[TBL] [Abstract][Full Text] [Related]
4. CD10, BCL6, and MUM1 expression in diffuse large B-cell lymphoma on FNA samples.
Cozzolino I; Varone V; Picardi M; Baldi C; Memoli D; Ciancia G; Selleri C; De Rosa G; Vetrani A; Zeppa P
Cancer Cytopathol; 2016 Feb; 124(2):135-43. PubMed ID: 26414904
[TBL] [Abstract][Full Text] [Related]
5. BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma.
Iqbal J; Sanger WG; Horsman DE; Rosenwald A; Pickering DL; Dave B; Dave S; Xiao L; Cao K; Zhu Q; Sherman S; Hans CP; Weisenburger DD; Greiner TC; Gascoyne RD; Ott G; Müller-Hermelink HK; Delabie J; Braziel RM; Jaffe ES; Campo E; Lynch JC; Connors JM; Vose JM; Armitage JO; Grogan TM; Staudt LM; Chan WC
Am J Pathol; 2004 Jul; 165(1):159-66. PubMed ID: 15215171
[TBL] [Abstract][Full Text] [Related]
6. High frequency and strong prognostic relevance of O6-methylguanine DNA methyltransferase silencing in diffuse large B-cell lymphomas from the Middle East.
Al-Kuraya K; Narayanappa R; Siraj AK; Al-Dayel F; Ezzat A; El Solh H; Al-Jommah N; Sauter G; Simon R
Hum Pathol; 2006 Jun; 37(6):742-8. PubMed ID: 16733216
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiling of diffuse large B-cell lymphoma.
Rosenwald A; Staudt LM
Leuk Lymphoma; 2003; 44 Suppl 3():S41-7. PubMed ID: 15202524
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical classification of de novo, transformed, and relapsed diffuse large B-cell lymphoma into germinal center B-cell and nongerminal center B-cell subtypes correlates with gene expression profile and patient survival.
Haarer CF; Roberts RA; Frutiger YM; Grogan TM; Rimsza LM
Arch Pathol Lab Med; 2006 Dec; 130(12):1819-24. PubMed ID: 17149956
[TBL] [Abstract][Full Text] [Related]
9. Expression profiling analysis of the CD5+ diffuse large B-cell lymphoma subgroup: development of a CD5 signature.
Suguro M; Tagawa H; Kagami Y; Okamoto M; Ohshima K; Shiku H; Morishima Y; Nakamura S; Seto M
Cancer Sci; 2006 Sep; 97(9):868-74. PubMed ID: 16856881
[TBL] [Abstract][Full Text] [Related]
10. Clinical quantitation of diagnostic and predictive gene expression levels in follicular and diffuse large B-cell lymphoma by RT-PCR gene expression profiling.
Sakhinia E; Glennie C; Hoyland JA; Menasce LP; Brady G; Miller C; Radford JA; Byers RJ
Blood; 2007 May; 109(9):3922-8. PubMed ID: 17255358
[TBL] [Abstract][Full Text] [Related]
11. Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma.
Lossos IS; Jones CD; Warnke R; Natkunam Y; Kaizer H; Zehnder JL; Tibshirani R; Levy R
Blood; 2001 Aug; 98(4):945-51. PubMed ID: 11493437
[TBL] [Abstract][Full Text] [Related]
12. Clinical and prognostic significance of aberrant T-cell marker expression in 225 cases of de novo diffuse large B-cell lymphoma and 276 cases of other B-cell lymphomas.
Tsuyama N; Ennishi D; Yokoyama M; Baba S; Asaka R; Mishima Y; Terui Y; Hatake K; Takeuchi K
Oncotarget; 2017 May; 8(20):33487-33500. PubMed ID: 28380441
[TBL] [Abstract][Full Text] [Related]
13. [Large-cell diffuse B-cell lymphoma: heterogenous origin and prognosis from the aspect of modern diagnosis].
Soukup J; Krsková L; Mrhalová M; Kodet R; Campr V; Kubácková K; Trnĕný M
Cas Lek Cesk; 2003; 142(7):417-22. PubMed ID: 14515445
[TBL] [Abstract][Full Text] [Related]
14. Profiling of apoptosis genes allows for clinical stratification of primary nodal diffuse large B-cell lymphomas.
Muris JJ; Ylstra B; Cillessen SA; Ossenkoppele GJ; Kluin-Nelemans JC; Eijk PP; Nota B; Tijssen M; de Boer WP; van de Wiel M; van den Ijssel PR; Jansen P; de Bruin PC; van Krieken JH; Meijer GA; Meijer CJ; Oudejans JJ
Br J Haematol; 2007 Jan; 136(1):38-47. PubMed ID: 17062006
[TBL] [Abstract][Full Text] [Related]
15. Rearrangement of the BCL6 locus at 3q27 is an independent poor prognostic factor in nodal diffuse large B-cell lymphoma.
Barrans SL; O'Connor SJ; Evans PA; Davies FE; Owen RG; Haynes AP; Morgan GJ; Jack AS
Br J Haematol; 2002 May; 117(2):322-32. PubMed ID: 11972514
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of germinal center-associated proteins and chromosomal breakpoints in poor-risk diffuse large B-cell lymphoma.
van Imhoff GW; Boerma EJ; van der Holt B; Schuuring E; Verdonck LF; Kluin-Nelemans HC; Kluin PM
J Clin Oncol; 2006 Sep; 24(25):4135-42. PubMed ID: 16943530
[TBL] [Abstract][Full Text] [Related]
17. [Survival of patients with primary central nervous system diffuse large B-cell lymphoma: impact of gene aberrations and protein overexpression of bcl-2 and C-MYC, and selection of chemotherapy regimens].
Yin WJ; Zhu X; Yang HY; Sun WY; Wu MJ
Zhonghua Bing Li Xue Za Zhi; 2018 Jan; 47(1):32-38. PubMed ID: 29325248
[No Abstract] [Full Text] [Related]
18. Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma.
Kramer MH; Hermans J; Wijburg E; Philippo K; Geelen E; van Krieken JH; de Jong D; Maartense E; Schuuring E; Kluin PM
Blood; 1998 Nov; 92(9):3152-62. PubMed ID: 9787151
[TBL] [Abstract][Full Text] [Related]
19. Molecular diagnosis and outcome prediction in diffuse large B-cell lymphoma and other subtypes of lymphoma.
Dybkaer K; Iqbal J; Zhou G; Chan WC
Clin Lymphoma; 2004 Jun; 5(1):19-28. PubMed ID: 15245604
[TBL] [Abstract][Full Text] [Related]
20. Gene profiling of canine B-cell lymphoma reveals germinal center and postgerminal center subtypes with different survival times, modeling human DLBCL.
Richards KL; Motsinger-Reif AA; Chen HW; Fedoriw Y; Fan C; Nielsen DM; Small GW; Thomas R; Smith C; Dave SS; Perou CM; Breen M; Borst LB; Suter SE
Cancer Res; 2013 Aug; 73(16):5029-39. PubMed ID: 23783577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
